Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Crestani

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal of Thrombosis and Thrombolysis|November 13, 2012
Novel treatments for epistaxis in hereditary hemorrhagic telangiectasia: a systematic review of the clinical experience with thalidomideMassimo Franchini, Francesco Frattini, Silvia Crestani, et al.
Hematology (Amsterdam, Netherlands)|February 12, 2013
Alloantibodies in previously untreated hemophilia A patients: the role of environmental factorsMassimo Franchini, Francesco Frattini, Silvia Crestani, et al.
Seminars in Thrombosis and Hemostasis|December 19, 2012
Bleeding complications in patients with hematologic malignanciesMassimo Franchini, Francesco Frattini, Silvia Crestani, et al.
Journal of Thrombosis and Thrombolysis|October 16, 2012
Acquired FXIII inhibitors: a systematic reviewMassimo Franchini, Francesco Frattini, Silvia Crestani, et al.
Expert Opinion on Pharmacotherapy|September 6, 2012
Haemophilia B: current pharmacotherapy and future directionsMassimo Franchini, Francesco Frattini, Silvia Crestani, et al.
Hematology (Amsterdam, Netherlands)|January 17, 2013
Pure white cell aplasia induced by mesalazine in a patient with ulcerative colitisFrancesco Frattini, Silvia Crestani, Pier Paolo Vescovi, et al.
Blood Transfusion = Trasfusione Del Sangue|December 30, 2014
Role of rituximab in the treatment of postpartum acquired haemophilia A: a systematic review of the literatureCarlo Bonfanti, Silvia Crestani, Francesco Frattini, et al.
Biologics : Targets & Therapy|February 23, 2013
Treatment of hemophilia B: focus on recombinant factor IXMassimo Franchini, Francesco Frattini, Silvia Crestani, et al.
Seminars in Thrombosis and Hemostasis|June 18, 2014
Hemostatic agents for bleeding: recombinant-activated factor VII and beyondMassimo Franchini, Silvia Crestani, Francesco Frattini, et al.
Clinical Chemistry and Laboratory Medicine|June 20, 2014
ABO blood group and von Willebrand factor: biological implicationsMassimo Franchini, Silvia Crestani, Francesco Frattini, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Thrombosis and Thrombolysis|November 13, 2012
Novel treatments for epistaxis in hereditary hemorrhagic telangiectasia: a systematic review of the clinical experience with thalidomideMassimo Franchini, Francesco Frattini, Silvia Crestani, et al.
Hematology (Amsterdam, Netherlands)|February 12, 2013
Alloantibodies in previously untreated hemophilia A patients: the role of environmental factorsMassimo Franchini, Francesco Frattini, Silvia Crestani, et al.
Seminars in Thrombosis and Hemostasis|December 19, 2012
Bleeding complications in patients with hematologic malignanciesMassimo Franchini, Francesco Frattini, Silvia Crestani, et al.
Journal of Thrombosis and Thrombolysis|October 16, 2012
Acquired FXIII inhibitors: a systematic reviewMassimo Franchini, Francesco Frattini, Silvia Crestani, et al.
Expert Opinion on Pharmacotherapy|September 6, 2012
Haemophilia B: current pharmacotherapy and future directionsMassimo Franchini, Francesco Frattini, Silvia Crestani, et al.
Hematology (Amsterdam, Netherlands)|January 17, 2013
Pure white cell aplasia induced by mesalazine in a patient with ulcerative colitisFrancesco Frattini, Silvia Crestani, Pier Paolo Vescovi, et al.
Blood Transfusion = Trasfusione Del Sangue|December 30, 2014
Role of rituximab in the treatment of postpartum acquired haemophilia A: a systematic review of the literatureCarlo Bonfanti, Silvia Crestani, Francesco Frattini, et al.
Biologics : Targets & Therapy|February 23, 2013
Treatment of hemophilia B: focus on recombinant factor IXMassimo Franchini, Francesco Frattini, Silvia Crestani, et al.
Seminars in Thrombosis and Hemostasis|June 18, 2014
Hemostatic agents for bleeding: recombinant-activated factor VII and beyondMassimo Franchini, Silvia Crestani, Francesco Frattini, et al.
Clinical Chemistry and Laboratory Medicine|June 20, 2014
ABO blood group and von Willebrand factor: biological implicationsMassimo Franchini, Silvia Crestani, Francesco Frattini, et al.
Pageof 3